Posts

Associations of health status and conformation with longevity and lifetime competition performance in young Swedish Warmblood riding horses: 8,238 cases ( 1983-2005)

Abstract
Journal of the American Veterinary Medical Association
June 15, 2014, Vol. 244, No. 12, Pages 1449-1461

Lina Jönsson, PhD; Agneta Egenvall, DVM, PhD; Lars Roepstorff, DVM

Design—Cohort study and genetic analysis.

Animals—8,238 horses.

Procedures—Horses were examined for health, conformation, and performance from 1983 to 2005, when they were 4 to 5 years old, and competition results from 1983 to 2012 were evaluated. Associations between conformation, health, and talent scores of young horses and longevity (years in competition) and lifetime performance were analyzed. Odds ratios of competing later in life among horses with joint flexion test reactions were determined. Genetic correlations between young horse health, conformation, and talent scores and longevity and lifetime performance were determined.

Results—Good overall 4- to 5-year-old health, conformation, and talent scores for performance were phenotypically and genetically associated with greater longevity and lifetime performance. Good health was genetically correlated (rg = 0.3) to longevity and lifetime performance. Among conformation traits, body type and movements in the trot were most strongly associated with future longevity; these were genetically correlated (rg = 0.2 to 0.3) to longevity and lifetime performance. Intermediate-sized horses were associated with highest longevity and lifetime performance. Positive flexion test results were associated with lower ORs (OR, 0.59 for moderate to severe and 0.76 for minor reactions) of competing later in life, compared with no reaction, and were associated with lower longevity (0.4 years).

Conclusions and Clinical Relevance—Horses with good health and conformation at a young age had better longevity in competitions than the mean. Positive correlations suggested that improvement of health and conformation of young horses will enhance their future athletic talent and performance.

Manuka Honey and Wound Care

Manuka Honey and Wound Care
by Nancy Loving

With increasing emphasis by horse owners on approaching their horses’ health issues through more “holistic” and “natural” strategies, one such “natural” and relatively inexpensive treatment might include the use of honey for wound care. As a veterinarian you need to understand the physical and financial aspects of potentially using this option.

Honey application to cutaneous wounds is far from a “new” treatment; honey has been used since Egyptian times dating as far back as 2,000 B.C. as a means of managing wounds and inhibiting bacterial infection.

Yet it is important to know that not all honey is created equal. Manuka honey, derived from floral sources Leptosperum spp in New Zealand and Australia, has specific antibacterial and antioxidant properties that are absent in other honeys. Manuka honey is reported to have osmotic and pH effects; for example, it creates a more acidic pH environment that counteracts the alkaline pH of an infected wound, which is helpful for wound contraction. By lowering wound pH, protease activity is decreased and fibroblast activity and oxygen release are increased, all of which facilitate wound healing.

In addition, while bacterial-generated biofilm is known to impair healing, manuka honey has potent anti-biofilm properties: methylglyoxal, the bactericidal component of manuka honey, kills biofilm-embedded bacteria.

With the resurgence of the use of honey for wound care, licensed, medical-grade manuka honey is commercially available in therapeutic wound dressings: Medihoney  (Derma Sciences) and Active Manuka Honey UMF 18+ (Manuka Honey USA). A medical-grade product is one that has been “sterilized by gamma irradiation and has a standardized antibacterial activity.”

Use of non-sterilized honey has the potential to contaminate a wound with aerobic bacteria or fungi, therefore it should not be used.

Application of medical-grade manuka honey on a wound has the potential to reduce both the duration and expense of systemic antibiotic treatment while achieving favorable therapeutic results for the patient and client.